A phase I trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomas

Authors :: Michael D. Prados
Jane Rabbitt
Ashley A. DeSilva
Daryl C. Drummond
Nicholas Butowski
Jennifer Leigh Clarke
Susan M. Chang
Annette M. Molinaro
Source :: Journal of Clinical Oncology. 33:2029-2029
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: 2029 Background: Treatment options for recurrent malignant glioma are limited. Preclinical activity of irinotecan has been seen in glioma models but only modest efficacy has been noted in clinical ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Treatment options
medicine.disease
nervous system diseases
Surgery
Irinotecan
Internal medicine
Glioma
medicine
Liposomal Irinotecan
In patient
business
neoplasms
medicine.drug

Tools